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Abstract
While image analysis of chest computed tomography (CT) for COVID-19 di-
agnosis has been intensively studied, little work has been performed for image-
based patient outcome prediction. Management of high-risk patients with early
intervention is a key to lower the fatality rate of COVID-19 pneumonia, as a
majority of patients recover naturally. Therefore, an accurate prediction of dis-
ease progression with baseline imaging at the time of the initial presentation
can help in patient management. In lieu of only size and volume information
of pulmonary abnormalities and features through deep learning based image
segmentation, here we combine radiomics of lung opacities and non-imaging
features from demographic data, vital signs, and laboratory findings to predict
need for intensive care unit (ICU) admission. To our knowledge, this is the first
study that uses holistic information of a patient including both imaging and
non-imaging data for outcome prediction. The proposed methods were thor-
oughly evaluated on datasets separately collected from three hospitals, one in
the United States, one in Iran, and another in Italy, with a total 295 patients
with reverse transcription polymerase chain reaction (RT-PCR) assay positive
COVID-19 pneumonia. Our experimental results demonstrate that adding non-
imaging features can significantly improve the performance of prediction to
achieve AUC up to 0.884 and sensitivity as high as 96.1%, which can be valu-
able to provide clinical decision support in managing COVID-19 patients. Our
methods may also be applied to other lung diseases including but not limited
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to community acquired pneumonia.
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1. Introduction
Coronavirus disease 2019 (COVID-19), which results from contracting an
extremely contagious beta-coronavirus, is responsible for the latest pandemic
in human history. The resultant lung injury from COVID-19 pneumonia can
progress rapidly to diffuse alveolar damage, acute lung failure, and even death
[1, 2]. Given the highly contagious nature of the infection, the burden of COVID-
19 pneumonia has imposed substantial constraints on the global healthcare sys-
tems. In this paper, we present a novel framework of integrative analysis of
heterogeneous data including not only medical images, but also patient demo-
graphic information, vital signs and laboratory blood test results for assessing
disease severity and predicting intensive care unit (ICU) admission of COVID-
19 patients. Screening out the high-risk patients, who may need intensive care
later, and monitoring them more closely to provide early intervention may help
save their lives.
Reverse transcription polymerase chain reaction (RT-PCR) assay with de-
tection of specific nuclei acid of SARS-CoV-2 in oral or nasopharyngeal swabs
is the preferred test for diagnosis of COVID-19 infection. Although chest com-
puted tomography (CT) can be negative in early disease, it can achieve higher
than 90% sensitivity in detecting COVID-19 pneumonia but with low specificity
[3]. For diagnosis of COVID-19 pneumonia, CT is commonly used in regions
with high prevalance and limited RT-PCR availability as well as in patients
with suspected false negative RT-PCR. CT provides invaluable information in
patients with moderate to severe disease to assess the severity and complications
of COVID-19 pneumonia [4]. Prior clinical studies with chest CT have reported
that qualitative scoring of lung lobar involvement by pulmonary opacities (high
lobar involvement scores) can help assess severe and critical COVID-19 pneu-
monia. Li et al. [5] showed that high CT severity scores (suggestive of exten-
sive lobar involvement) and consolidation are associated with severe COVID-19
pneumonia. Zhao et al. [6] reported that extent and type of pulmonary opaci-
ties can help establish severity of COVID-19 pneumonia. The lung attenuation
values change with the extent and type of pulmonary opacities, which differ
in patients with more extensive, severe disease from those with milder disease.
Most clinical studies focus on qualitative assessment and grading of pulmonary
involvement in each lung lobe to establish disease severity, which is both time-
consuming and associated with interobserver variations [6, 7].
To address the urgent clinical needs, artificial intelligence (AI), especially
deep learning, has been applied to COVID-19 CT image analysis [8]. AI has been
used to differentiate COVID-19 from community acquired pneumonia (CAP)
on chest CT images [9, 10]. To unveil what deep learning uses to diagnose
COVID-19 from CT, Wu et al. [11] proposed an explainable diagnosis system
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by classifying and segmenting infections. Gozes et al. [12] developed a deep
learning based pipeline to segment lung, classify 2D slices and localize COVID-
19 manifestation from chest CT scans. Shan et al. [13] went on to quantify lung
infection of COVID-19 pneumonia from CT images using deep learning based
image segmentation.
Among the emerging works, a few AI based methods target at severity as-
sessment from chest CT. Huang et al. [14] developed a deep learning method to
quantify severity from serial chest CT scans to monitor the disease progression
of COVID-19. Tang et al. [15] used random forest to classify pulmonary opacity
volume based features into four severity groups. By automatically segmenting
the lung lobes and infection areas, Gozes et al. [16] suggested a “Corona Score”
to measure the progression of disease over time. Zhu et al. [17] further proposed
to use AI to predict if a patient may develop severe symptoms of COVID-19 and
how long it may take if that is the case. Although promising results have been
presented, the existing methods primarily focus on the volume of pulmonary
opacities and their relative ratio to the lung volume for severity assessment.
The type of pulmonary opacities (e.g. ground glass, consolidation, crazy-paving
pattern, organizing pneumonia) is also an important indicator of the stage of
the disease and is often not quantified by the AI algorithms [18].
Furthermore, in addition to measuring and monitoring the progression of
severity, it could be life-saving to predict mortality risk of patients by learning
from the clinical outcomes. Since majority of the infected patients will recover,
managing the high-risk patients is the key to lower the fatality rate [19, 20,
21]. Longitudinal study analyzing the serial CT findings over time in patients
with COVID-19 pneumonia shows that the temporal changes of the diverse
CT manifestations follow a specific pattern correlating with the progression
and recovery of the illness [22]. Thus, it is promising for AI to perform this
challenging task.
In this paper, our objective is to predict outcome of COVID-19 pneumonia
patients in terms of the need for ICU admission with both imaging and non-
imaging information. The work has two major contributions.
1. While image features have been commonly exploited by the medical image
analysis community for COVID-19 diagnosis and severity assessment, non-
imaging features are much less studied. However, non-imaging health data
may also be strongly associated with patient severity. For example, Yan
et al. [23] showed that machine learning tools using three biomarkers,
including lactic dehydrogenase (LDH), lymphocyte and high-sensitivity C-
reactive protein (hs-CRP), can predict the mortality of individual patients.
Thus, we propose to integrate heterogeneous data from different sources,
including imaging data, age, sex, vital signs, and blood test results to
predict patient outcome. To the best of our knowledge, this is the first
study that uses holistic information of a patient including both imaging
and non-imaging data for outcome prediction.
2. In addition to the simple volume measurement based image features, ra-
diomics features are computed to describe the texture and shape of pul-
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monary opacities. A deep learning based pyramid-input pyramid-output
image segmentation algorithm is used to quantify the extent and volume
of lung manifestations. A feature dimension reduction algorithm is further
proposed to select the most important features, which is then followed by
a classifier for prediction.
It is worth noting that although the presented application on COVID-19 pneu-
monia, the proposed method is a general approach and can be applied to other
diseases.
The proposed method was evaluated on datasets collected from teaching
hospitals across three countries, These datasets included 113 CT images from
Firoozgar Hospital (Tehran, Iran)(Site A), 125 CT images from Massachusetts
General Hospital (Boston, MA, USA)(Site B), and 57 CT images from Univer-
sity Hospital Maggiore della Carita (Novara, Piedmont, Italy)(Site C). Promis-
ing experimental results for outcome prediction were obtained on all the datasets
with our proposed method, with reasonable generalization across the datasets.
Details of our work are presented in the following sections.
2. Data and Annotation
2.1. Data sets
The data used in our work were acquired from three sites. All the CT imaging
data were from patients who underwent clinically indicated, standard-of-care,
non-contrast chest CT without intravenous contrast injection. Age and gender
of all patients were recorded. For datasets from Sites A and B, lymphocyte
count and white blood cell count were also available. For datasets of Sites A and
C, peripheral capillary oxygen saturation (SpO2) and temperature on hospital
admission were recorded. Information pertaining patient status (discharged,
deceased, or under treatment at the time of data analysis) was also recorded as
well as the number of days of hospitalization to the outcome.
Site A Dataset. We reviewed medical records of adult patients admitted with
known or suspected COVID-19 pneumonia in Firoozgar Hospital (Tehran, Iran)
between February 23, 2020 and March 30, 2020. Among the 117 patients with
positive RT-PCR assay for COVID-19, three patients were excluded due to
presence of extensive motion artifacts on their chest CT. With one patient who
neither admitted to ICU nor discharged, 113 patients are used in this study.
Site B Dataset. We reviewed medical records of adult patients admitted with
COVID-19 symptom in MGH between March 11 and May 3, 2020. 125 RT-PCR
positive admitted patients underwent unenhanced chest CT are selected to form
this dataset.
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Site C Dataset. We reviewed medical records of adult patients admitted with
COVID-19 pneumonia in the Novara Hospital (Piedmont, Italy) between March
4, 2020 and April 6, 2020. We collected clinical and outcome information of 57
patients with positive RT-PCR assay for COVID-19.
Two experienced thoracic subspecialty radiologists evaluated all chest CT
examinations and recorded opacity type, distribution and extent of lobar in-
volvement. Information on symptom duration prior to hospital admission, du-
ration of hospital admission, presence of comorbid conditions, laboratory data,
and outcomes (recovery or death) was obtained from the medical records. En-
tire lung volume was segmented on thin-section DICOM images (1.5-2 mm) to
obtain whole-lung analysis. Statistics of the datasets are shown in Tables 3-5 in
Section 3.4.
2.2. Annotation of severity
Two chest radiologists (SRD with 16 years of experience, MKK with 14
years of experience) reviewed all CTs unware of the information on clinical fea-
tures, laboratory data, and outcomes information. On an imaging workstation
(MicroDicom DICOM Viewer, Sofia, Bulgaria), images were reviewed in lung
windows (window center -600 HU; window width 1500 HU). The radiologists
noted the opacities type (pure ground-glass, mixed ground-glass and consolida-
tion, pure consolidation, organizing pneumonia, nodular and ground-glass with
interlobular thickening (crazy-paving pattern)) and extent of individual lobe
involvement of right upper, left upper, right middle, right lower and left lower
lobes. The latter was assessed on a 6-point scale (0% lobar involvement = score
0; <5% involvement of lobar volume = score 1; 5-25% involvement of lobe =
score 2; 26-50% lobar involvement = score 3; 51-75% lobar involvement = score
4; >75% lobar involvement = score 5) [13]. Addition of individual extent scores
provided the overall extent of pulmonary opacities with a minimum possible
score of 0 and maximum score of 25 [9, 13].
3. ICU Admission Prediction
In order to predict the need for ICU admission of patients with COVID-
19 pneumonia, we use three types of imaging and non-imaging features. Our
adopted features include hierarchical lobe-wise quantification features (HLQ),
whole lung radiomics features (WLR), and features from demographic, vital
signs, and blood examination (DVB). Figure 1 shows an overview of the overall
framework of the presented work. In the rest of this section, we first introduce
the details of these features. Since it is challenging to fuse the large number
of inhomogeneous features together, a feature selection strategy is proposed,
followed by random forest based classification [24].
3.1. Deep Learning based Image Segmentation
In our work, we employed deep neural networks to segment both lungs, five
lung lobes and pulmonary opacities (as regions of infection) from non-contrast
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Figure 1: Framework of the proposed methods including the utilized inputs and expected
output.
chest CT examinations. For training purpose, we semi-automatically labeled
71 CT volumes using 3D Slicer [25]. For lung lobe segmentation, we adopted
the automated lung segmentation method by Hofmanninger et al. [26]. The
pre-trained model1 was fine-tuned with a learning rate of 1 × 10−5 using our
annotated data. The tuned model was then applied to segment all the chest CT
volumes.
Segmentation of pulmonary opacities was completed by our previously pro-
posed method, Pyramid Input Pyramid Output Feature Abstraction Network
(PIPO-FAN) [27] with publicly released source code2.
Figure 2 shows the segmentation results of lung lobes and pulmonary opac-
ities. From axial and 3D view, we can see that the segmentation models can
smoothly and accurately predict isolate regions with pulmonary opacities.
3.2. Hierarchical Lobe-wise Quantification Features
Based on the segmentation results in Section 3.1, we then compute the ratio
of opacity volume over different lung regions, which is a widely used measure-
ment to describe the severity [15, 17]. The lung regions include the whole lung,
the left lung and the right lung and 5 lung lobes (lobe# 1-5) as shown in Fig-
ure 2. The right lung includes upper lobe (lobe# 1) , middle lobe (lobe# 2), and
lower lobe (lobe# 3), while left lung includes upper lobe(lobe# 4) and lower lobe
1https://github.com/JoHof/lungmask
2https://github.com/DIAL-RPI/PIPO-FAN
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(a) COVID-19 CT image (b) Lobes and infection (c) 3D Visualization
Figure 2: Lung lobes and pulmonary opacities segmentation results. Areas colored in magenta
indicate the segmented lesions.
Table 1: Radiomics feature types and number of each kind of features.
Group Feature type # features Sum
Texture
First order 18
93
GLCM 24
GLRLM 16
GLSZM 16
NGTDM 5
GLDM 14
Shape Shape (3D) 17 17
(lobe# 5). Thus, each CT image has 8 regions of interest (ROIs). In addition to
the ROI segmentation, we partitioned each segment to 4 parts based on the HU
ranges, i.e., the HU ranges of -∞ to -750 (HU[-∞, -750]), -750 to -300 (HU[-750,
-300]), -300 to 50 (HU[-300, 50]), and 50 to +∞ (HU[50, +∞]). These four HU
ranges correspond to normal lungs, ground glass opacity (GGO), consolidation,
and regions with pulmonary calcification, respectively. As a result, each CT
image was partitioned to 32 components (8 ROIs × 4 ranges/ROI).
We extracted two quantitative features from each part, i.e., volumes of pul-
monary opacities (VPO) and ratio of pulmonary opacities to the corresponding
component (RPO), as defined below:
V PO(x) = V (Segment(x)) (1)
RPO(x) =
V PO(x)
V (x)
=
V (Segment(x))
V (x)
(2)
where x is a selected component (among the 32 components). Segment(x)
denotes the pulmonary opacities in the selected component x based on the
segmentation of pulmonary opacities in Figure 2. V (·) denotes the volume of
the selected part.
3.3. Whole Lung Radiomics Features
To more comprehensively describe information in the CT image, we also
extracted multi-dimensional radiomics features [28] of all pulmonary opacities.
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Table 2: Image filter types and extracted radiomics features from each type of filtered images.
Image filter type Extracted features # features
No filter (Original image) Texture + Shape 93+17=110
Square filter Texture 93
Square-root(Sqrt) filter Texture 93
Logarithm filter Texture 93
Exponential filter Texture 93
Wavelet filters
Texture 93×8=744(HHH, HHL, HLH, LHH,
HLL, LHL, LLH, LLL)
Laplacian of Gaussian (LoG) filters
Texture 93×5=465
σ ∈ {0.5, 1.5, 2.5, 3.5, 4.5}
Compared with HLQ feature, although they are all image-based features, they
describe the pulmonary opacities from different aspects. HLQ features focus on
the pulmonary opacities volume and position of region of interest, while WLR
focus on their shape and texture.
For each chest CT volume, we first masked out non-infection regions based
on the infection segmentation results, then four kinds of radiomics features
are calculated on the volume, i.e., shape, first-order, second-order and higher-
order statistics features [29]. Shape features describe the geometric informa-
tion. First-order, second-order and higher-order statistics features all describes
texture information. First-order statistics features describe the distribution of
individual voxel values without concerning spatial correlation. Second-order
features describe local structures, which provide correlated information be-
tween adjacent voxels and statistical measurement of intra-lesion heterogeneity.
Second-order features include those extracted using gray level dependence ma-
trix (GLDM), gray level co-occurrence matrix (GLCM), grey level run length
matrix (GLRLM), grey level size zone matrix (GLSZM), and neighboring gray
tone difference matrix (NGTDM). Higher-order statistics features are computed
using the same methods as second-order features but after applying wavelets
and Laplacian transform of Gaussian(LoG) filters. The higher-order features
help identify repetitive patterns in local spatial-frequency domain in addition
to suppressing noise and highlighting details of images.
We used the Pyradiomics package [30] to extract the above described ra-
diomics features from COVID19 chest CT images. For each chest CT volume, a
total of 1691 features are extracted. The number of radiomics features for each
feature type are summarized in Table 1. Based on the description above, these
features can be categorized into two main groups, i.e., 17 shape features and 93
texture features.
To extracted various features, different image filters are applied before fea-
ture extraction. Table 2 shows the details of all 18 image filter types used in our
work, including no filter, square filter, square-root filter, logarithm filter, expo-
nential filter, wavelet filter and LoG filter. The image filtered by a 3D wavelet
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filter has eight channels, including HHH, HHL, HLH, LHH, HLL, LHL, LLH and
LLL. The Laplacian of Gaussian (LoG) filters have a hyper-parameter σ which
is the standard deviation of the Gaussian distribution. We used five different
σ values in our study, i.e., {0.5, 1.5, 2.5, 3.5, 4.5}. Note that shape features are
only extracted from the original images (no filter was applied).
3.4. Non-imaging Features
Table 3: Statistics (mean±std, except for gender) of DVB features for Site A dataset.
ICU admission Not Admitted ICU Admitted Data #
Gender (M:F) 43 : 28 29 : 13 113
Age (year) 56.7 ± 16.0 66.9 ± 16.2 113
Lym r (%) 22.7 ± 8.3 15.6 ± 12.8 113
WBC 5831.0 ± 1848.9 7966.7 ± 4556.2 113
Lym 1244.7 ± 482.8 1010.4 ± 943.7 113
Temperature (℃) 37.3 ± 0.6 37.6 ± 0.6 98
SpO2 (%) 91.9 ± 7.41 86.5 ± 8.53 100
Table 4: Statistics (mean±std, except for gender) of DVB features for Site B dataset.
ICU admission Not Admitted ICU Admitted Data #
Gender (M:F) 23 : 24 39 : 39 125
Age (year) 74.8 ± 15.0 72.7 ± 11.1 125
Lym r (%) 18.6 ± 12.7 13.0 ± 12.8 125
WBC 7175.7 ± 4288.9 11722.3 ± 7249.3 125
Lym 1058.1 ± 596.7 1613.8 ± 3872.7 125
Table 5: Statistics (mean±std, except for gender) of DVB features for Site C dataset.
ICU admission Not Admitted ICU Admitted Data #
Gender (M:F) 13 : 8 24 : 12 57
Age (year) 70.0 ± 13.7 66.9 ± 12.3 57
Temperature (℃) 39.0 ± 1.0 37.8 ± 0.9 50
SpO2 (%) 92.3 ± 5.25 84.5 ± 7.74 31
In addition to features extracted from images, we incorporated features from
demographic data (contained by all three datasets), vital signs (from Sites A and
B), and laboratory data (from Sites A and C) (DVB). Specifically, such features
include patients’ age, gender, white blood cell count (WBC), lymphocyte count
(Lym), Lym to WBC ratio (L/W ratio), temperature and blood oxygen level
(SpO2). These data are highly correlated with the ICU admission of patients
when they were admitted to a hospital. Table 3-5 show the statistics of the
above features in Site A, Site B, and Site C datasets respectively. Non-imaging
features are not all available for some patients. The number of the collected
data for each feature is listed in the last column of the tables.
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3.5. ICU Admission Prediction
In our work, random forest (RF) [24] classifier, a widely-used ensemble learn-
ing method consisting of multiple decision trees, is chosen for predicting ICU
admission due to its several nice properties. First, RF is robust to small data
size. Second, it can generate feature importance ranking and is thus highly
interpretable. Aggregating all the features introduced above, we have 1,762 fea-
tures in total. Due to the limited data size, the model would easily overfit with
all features as input. Thus, we first used RF to rank all the features, then we
selected the top K features for our final prediction.
We ranked the feature based on their Gini importance [31]. It is calculated
during the training of RF by averaging the decrease of Gini impurity over all
trees. Due to the randomness of RF, Gini importance of features may vary when
RF model is initialized with different random seeds. Therefore, in our study,
feature ranks are computed 100 times with different random seeds. Each time
every feature will get a score being its rank. The final feature rank is obtained
by sorting the total summed score of each feature.
Based on the rank of all the features, we select top K ∈[1,100] features to
train the RF model and calculate the prediction performance in terms of AUC.
4. Experimental Results
This section presents the experimental results of the developed methods. We
show the effectiveness of our proposed method on the three datasets separately
through both ablation studies and comparison with other state-of-the-art ap-
proaches. We did not merge the datasets because of two reasons. First, not all
the non-image features were available from the participating sites. Second, the
treatment and admission criteria at the participating sites were likely different
from each other. Thus, it would not be rigorous to merge the datasets. First,
on each dataset the proposed methods with different combinations of features
is compared with other state-of-the-art approaches. In this part of experiments,
we also included results of a deep learning network which take the best feature
combination as input. The deep learning network is composed by three fully
connected layers with output dimension of 64, 16 and 2 respectively. Dropout
was applied on the first two layers with p= 50%. The cross entropy loss is used
to train the network. In five fold cross validation, 3 folds are used to train the
network, one fold is leaved as validation set, and the other one is used as test
set. Second, the generalization ability of the feature combination learned by our
model is studied across three datasets.
Several recent works have shown the importance of using machine learning
models to predict patients’ outcomes based on lobe-wise quantification features.
The infection volume and infection ratio of the whole lung, right/left lung,
and each lobe/segment are calculated as quantitative features in [15]. Random
forest classifier is used to select the top-ranking features and make the severity
assessment based on these features. In another work by Zhu et al. [17], the
authors present a novel joint regression and classification method to identify
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the severity cases and predict the conversion time from a non-severe case to
the severe case. Their lobe-wised quantification features include the infection
volume, density feature and mass feature. As we mentioned earlier, all existing
image analysis-based outcome prediction works use only image features. We
take the features in the two papers as baseline to compare with our work.
4.1. Results on Site A Dataset
Table 6: Comparison of the proposed methods with different feature combinations on ICU
admission prediction on Site A dataset. One-tailed t-test is used to evaluate the statistical
significance between a method and the best performer.
Features
AUC Sensitivity (PPV=70%)
K
Mean 95% CI p Value Mean 95% CI p Value
Image features in [15] 0.818 (0.796, 0.839) p < .001 51.0% (39.3%, 62.6%) p < .001 8
Image features in [17] 0.776 (0.762, 0.790) p < .001 48.6% (35.4%, 61.7%) p = .001 46
DVB 0.855 (0.844, 0.866) p = .002 76.7% (73.2%, 80.1%) p = .017 1
HLQ 0.789 (0.781, 0.797) p < .001 51.4% (45.3%, 57.5%) p < .001 21
WLR 0.859 (0.843, 0.873) p < .001 71.4% (60.5%, 82.3%) p = .022 70
WLR+HLQ 0.866 (0.857, 0.875) p < .001 68.6% (57.6%, 79.5%) p = .008 61
WLR+DVB 0.876 (0.867, 0.886) p=.109 81.4% (76.0%, 86.8%) p=.152 4
HLQ+DVB 0.865 (0.844, 0.885) p=.080 70.0% (60.9%, 79.1%) p = .012 4
WLR+HLQ+DVB 0.884 (0.875, 0.893) - 84.3% (79.9%, 88.7%) - 52
Deep NN 0.751 (0.723, 0.779) p < .001 25.7% (0.8%, 50.6%) p = .003 ALL
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Figure 3: ROC curves of various feature combinations on Site A dataset. DVB: non-imaging
features including Demographic data, Vital signals and Blood test results; HLQ: Hierarchical
Lobe-wise Quantification features; WLR: Whole Lung Radiomics features.
Receiver Operating Characteristics (ROC) curves of the feature combina-
tions are shown in Figure 3. For each feature combination, the features are
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selected only from the feature categories available in the combination using the
approach introduced in Section 3.5. For example, HLQ+DVB indicates that
only features from these two groups, HLQ and DVB, are selected and used.
The number of features K used to obtain the best results are listed in Table 6.
To alleviate the stochasticity of the results, for each feature combination, five
RF models with different random seeds are trained and tested with five fold
cross validation. The curves shown here are thus the mean results of the five
models. The figure legend gives the mean Area Under the Curves (AUCs) of
the feature combinations as well as the standard deviation (mean±std). It can
be seen that the combination of all three kinds of features, WLR+HLQ+DVB,
obtained the best result with an AUC of 0.88±0.01. The variation of AUC along
with number of selected features on Site A dataset is presented in Fig. 4. As
marked by the light blue dash line in Fig. 4, AUC reaches the maximum value
when the top 52 features are selected. Details of the 52 selected features are
presented in Table 11 at the end of this paper due to its large size.
0 20 40 60 80 100
Number of Selected Features
0.83
0.84
0.85
0.86
0.87
0.88
0.89
AU
C
WLR+HLQ+DVB
Max AUC, Feature# = 52
Figure 4: Variation of AUC along choosing the top K features.
One-tailed t-test is used to evaluate the statistical significance between a
method and the best performer. Table 6 summarizes the AUC values and sen-
sitivity with significance test p values and 95% confidence interval (95% CI).
The classification threshold is selected by control the positive prediction value
(PPV) to be 70%. The combination of WLR+HLQ+DVB significantly exceeds
other reported methods [15, 17] with p ≤ 0.001. Further, we achieved a sensi-
tivity of 84.3% while retaining a PPV at 70%. It suggests that our model can
rapidly prioritize over 80% patients who would develop into critical conditions,
if we allow 3 false positive cases in every 10 positive predictions. With such
prediction, hospitals may allocate limited medical resources more efficiently to
potentially prevent such conversion and save more lives. Under the same set-
ting, the sensitivity of the model is 79.4%, the accuracy is 81.2%. The deep
learning model compared in Table 6 also used all three kinds of features.
In the comparison among different combinations of the features, we can
see that the results are generally improved with more feature sources added.
Comparison between WLR+HLQ (line 6) and WLR+HLQ+DVB (the last line)
shows that, on this dataset, introducing non-imaging features can significantly
improve the performance (p<0.001 for AUC and p=0.008<0.05 for sensitivity),
12
which further indicates that non-imaging features and image based features are
complementary. On the other hand, the comparison with WLR+DVB (line 7)
and HLQ+DVB (line 8) shows that the improvement of WLR+HLQ+DVB was
not significant (p>0.05). It suggests that different kinds of image based features
may contain redundant information and adding more features from the same
source only results in marginal improvement.
4.2. Results on Site B Dataset
Table 7: Comparison among the exist state-of-the-art methods and the proposed methods
with different feature combinations on Site B dataset.
Features
AUC Sensitivity (PPV=70%)
K
Mean 95% CI p Value Mean 95% CI p Value
Image features in [15] 0.770 (0.745, 0.796) p < .001 83.1% (75.8%, 90.4%) p = .009 10
Image features in [17] 0.767 (0.752, 0.781) p < .001 83.8% (82.2%, 85.5%) p < .001 39
DVB 0.671 (0.643, 0.700) p < .001 78.7% (69.7%, 87.7%) p = .007 4
HLQ 0.791 (0.774, 0.809) p < .001 84.6% (81.3%, 88.0%) p < .001 3
WLR 0.841 (0.827, 0.855) p = .014 94.9% (93.4%, 96.3%) - 55
WLR+HLQ 0.847 (0.833, 0.861) - 92.6% (89.5%, 95.7%) p = .083 12
WLR+DVB 0.841 (0.828, 0.854) p = .257 91.8% (90.5%, 93.1%) p = .012 33
HLQ+DVB 0.796 (0.777, 0.815) p = .001 84.4% (80.7%, 88.0%) p < .001 12
WLR+HLQ+DVB 0.844 (0.833, 0.855) p = .310 92.6% (90.0%, 95.1%) p = .027 4
Deep NN 0.704 (0.670, 0.738) p < .001 75.38% (71.6%, 79.2%) p < .001 ALL
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Figure 5: ROC curves on Site B dataset.
The same set of experiments were repeated on the Site B dataset. Table 7
and Fig. 5 shows the results. The number of features K used to obtain the
best results for each combination are listed in Table 7. It can be seen that, on
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Table 8: The top 12 features ranked in the order of importance on Site B dataset.
# Quantitative features # Quantitative features
1 Lobe#2 RPO HU3 2 Lobe#2 RPO HU2
3 Whole Lung RPO HU1 4 LoG(σ = 4.5)-firstorder-Kurtosis
5 Exponential-GLRLM-ShortRunLowGL 6 LoG(σ = 4.5)-NGTDM-Contrast
7 Exponential-GLRLM-ShortRun 8 LoG(σ = 3.5)-GLSZM-ZoneEntropy
9 LoG(σ = 4.5)-NGTDM-Busyness 10 Sqrt-NGTDM-Strength
11 LoG(σ = 3.5)-GLCM-Imc2 12 LLH-GLSZM-GLNonUnif
Green text indicates lobe-wise quantification features, HU1-HU4 are the four HU intervals.
Blue text indicates whole lung radiomics features encoded as Filter-FeatureType-
Parameter.
Site B dataset, non-imaging features are not very predictive. There could be
several reasons for the inability of DVB features on Site B dataset. First, as
shown in Table. 4 non-imaging features on Site B dataset have a large standard
deviation. Second, the use of CT in Site B is different from that in Site A.
Site B relied on chest radiography for most patients while CT was reserved for
more sicker patients or those with suspected complications; Site A used CT
in all patients regardless of clinical severity. Third, criteria of ICU admission
are different between two sites. Fourth, management strategies and disease
outcomes at the two sites are different. In this experiment, the best AUC value,
0.847, is achieved by merging two image-based feature, i.e., WLR+HLQ (line
6). With 70% PPV, WLR+HLQ obtained a sensitivity of 92.6%, a specificity of
37.0% and an accuracy of 71.7%. The best sensitivity (with PPV=70%), 94.9%
is obtained by WLR features. Although the sensitivity of WLR is higher than
WLR+HLQ, there is no significant difference (p = 0.083 > 0.05). The deep
learning model compared in Table 7 used the combination of WLR and HLQ.
Table 8 lists the 12 WLR+HLQ features used to obtain the best results.
4.3. Results on Site C Dataset
Table 9: Comparison among the exist state-of-the-art methods and the proposed methods
with different feature combinations on Site C dataset. As image features in [15] couldn’t
achieve 70% PPV, its sensitivity was not included.
Features
AUC Sensitivity (PPV=70%)
K
Mean 95% CI p Value Mean 95% CI p Value
Image features in [15] 0.763 (0.670, 0.856) p = .044 85.0% (76.4%, 93.6%) p = .020 10
Image features in [17] 0.675 (0.645, 0.706) p < .001 73.9% (59.0%, 88.8%) p < .011 39
DVB 0.595 (0.524, 0.665) p < .001 63.3% (36.1%, 90.5%) p = .019 4
HLQ 0.691 (0.660, 0.722) p < .001 86.7% (80.3%, 93.0%) p < .014 7
WLR 0.815 (0.782, 0.848) p = .020 95.6% (92.8%, 98.3%) p = .186 12
WLR+HLQ 0.826 (0.813, 0.839) p = .191 96.1% (94.4%, 97.8%) - 20
WLR+DVB 0.835 (0.809, 0.861) p = .365 95.0% (91.6%, 98.4%) p = .088 15
HLQ+DVB 0.760 (0.705, 0.815) p = .016 85.6% (77.6%, 93.5%) p < .010 2
WLR+HLQ+DVB 0.840 (0.804, 0.876) - 94.4% (92.3%, 966.6%) p = .035 35
Deep NN 0.568 (0.550, 0.587) p < .001 52.8% (29.2%, 76.4%) p = .005 ALL
Results on Site C dataset are shown in Table 9 and Fig. 5. The non-imaging
(DVB) features alone also didn’t achieve well performance. It might be because
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Figure 6: ROC curves on Site C dataset.
many petients’ DVB features are missing or incomplete as shown in Table. 5
Yet, the introduce of DVB features significantly improves the AUC performance
of HLQ features (p = 0.014 < 0.05). In this experiment, the best AUC value,
0.840, is achieved by merging all three kinds of features. While maintaining a
PPV of 70%, it achieved a sensitivity of 94.4%, a specificity of 33.3% and an
accuracy of 71.9%. The deep learning model compared in Table 9 used all three
kinds of data. Table 12 shows the 35 features used to obtain the best results at
the end of this paper due to its large size.
4.4. Generalization Ability
In this section, we further evaluate if feature combinations learned from one
site can be generated to other sites. Experiments on all 6 permutations are
conducted (train on Site A, test on Site B; train on Site A, test on Site C; train
on Site B, test on Site A; train on Site B, test on Site C; train on Site C, test
on Site A; train on Site C, test on Site B). Considering the 3 datasets contains
differet DVB features, WLR+HLQ features are used in this section. The results
are shown in Table 10.
There were tremendous differences in the geographic distribution and scan-
ner technologies used for imaging patients at the three participating sites. De-
spite this, we achieved AUC values as high as 0.754 for WLR+HLQ features.
Some variations in the AUCs and performance of our model across different
sites is expected due to challenges associated with acquisition of consistent data
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Table 10: Transferring WLR+HLQ features across the three datasets. Results on the diagonal
are obtained by models trained and tested on a single dataset with 5 fold cross validation.
Source
AUC (Best k) Target
A B C
A 0.866 (61) 0.740 (36) 0.685 (29)
B 0.754 (12) 0.847 (12) 0.633 (11)
C 0.591 (17) 0.717 (20) 0.826 (20)
variables and practices. Our study stresses the need to combine imaging find-
ings with clinical, laboratory and management variables which can improve the
model performance, aid in better performance statistics on each dataset. On
the other hand, complexities of disease and its outcomes are tied to local factors
and stress the importance of tweaking the best models based on rich local or
institutional level factors rather than a single one-type-fit-all model.
5. Discussion and Conclusions
In this paper, we propose to combine size and volume information of the
lungs and manifestations, radiomics features of pulmonary opacities and non-
imaging DVB features to predict need for ICU admission in patients with
COVID-19 pneumonia. Metrics related to ICU admission rates, need and avail-
ability are key markers in management of individual patients as well as in re-
source planning for managing high prevalence diseases. To the best of our
knowledge, this is the first study that uses holistic information of a patient
including both imaging and non-imaging data to predict patient outcome.
Although promising results were achieved, the study has a few limitations.
First of all, due to the limited size of our datasets, we could not conduct more
fine-grained outcome predictions. The size of the available datasets could also
be the reason that more complex models, such as deep neural networks, did
not perform well in our experiments. Once larger datasets are available, our
model can be rapidly adapted to assess generalization ability and to establish
implications on datasets from other sites. Efforts are underway (such as within
Radiological Society of North America) to establish such imaging datasets of
COVID-19 pneumonia. Second, variations in performance of different imaging
and clinical features on datasets from three sites underscore the need for careful
local vetting of deep learning predictive models. Future models should take into
account regional bias introduced from different criteria on imaging use, under-
lying patient comorbidities, and management strategies, so that more robust
models can be built. This also goes beyond the generalization ability of ma-
chine learning in medical applications. The best and most relevant results likely
require regional, local or even site-specific tuning of predictive models. This
is especially true in context of the three sites, which are under very different
healthcare systems as in our study. We believe that this limitation is not unique
to our model. Last but not the least, another limitation of our study pertains
to the lack of access to the specific treatment regimens at the three sites; their
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inclusion could have further enhanced the accuracy of our algorithm. However,
it also suggests that this generic approach can be trained on data from a hospital
to create a customized predictive model for clinical decision support.
In summary, our integrative analysis machine learning based predictive model
can help assess disease burden and forecast meaningful patient outcomes with
high predictive accuracy in patients with COVID-19 pneumonia. Many pa-
tients with adverse outcomes from COVID-19 pneumonia and cardiorespiratory
failure develop diffuse alveolar damage and adult respiratory distress syndrome
(ARDS), which are also well-known end stage manifestations of other pulmonary
diseases such as from other infections and lung injuries. Although we did not
test our model in patients with ARDS from non-COVID causes, given the over-
lap in imaging and clinical features of respiratory failure, we expect that the
methods of quantifying pulmonary opacities used in our approach will extend
beyond COVID-19 pneumonia. Further studies will help assess such applications
beyond the current pandemic of COVID-19 pneumonia.
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Table 11: The top 52 features ranked in the order of importance on Site A dataset.
# Quantitative features # Quantitative features
1 L/W ratio 2 Sqrt-NGTDM-Strength
3 LLL-GLDM-LowGray 4 Lobe#5 RPO HU4
5 Org-GLDM-LowGray 6 Lobe#5 RPO HU3
7 LLL-GLRLM-LongRunLG 8 Left Lung RPO HU4
9 Lym count 10 Lobe#2 VPO HU3
11 Lobe#2 VPO HU2 12 LLL-GLRLM-LGRun
13 LoG(σ = 1.5)-GLCM-MCC 14 LLL-GLSZM-LGZone
15 Org-NGTDM-Strength 16 Lobe#5 VPO HU3
17 Org-GLRLM-ShortRunLG 18 LLL-NGTDM-Strength
19 Org-GLRLM-LowGrayRun 20 LLL-GLDM-LargeDepdLG
21 LLL-GLRLM-ShortRunLG 22 LLL-GLSZM-SmallAreaLG
23 LLL-GLSZM-SmallAreaHG 24 LoG(σ = 2.5)-GLCM-MCC
25 WBC 26 Org-Shape-LeastAxisLength
27 Org-GLRLM-LongRunLG 28 LoG(σ = 1.5)-GLCM-Corr
29 Lobe#2 Infection Ratio HU4 30 HLL-FirstOrder-Mean
31 Left Lung VPO HU2 32 LoG(σ=2.5)-GLSZM-LALG
33 LLL-GLCM-JointAverage 34 Logarithm-NGTDM-Strength
35 Lobe#2 VPO HU4 36 HLH-GLSZM-Zone%
37 LoG(σ = 2.5)-GLCM-Corr 38 LLL-GLSZM-HGZone
39 Lobe#4 VPO HU4 40 LLL-GLCM-SumAverage
41 LoG(σ = 2.5)-NGTDM-Busyness 42 LLH-FirstOrder-Skewness
43 Lobe#2 RPO HU3 44 LoG(σ = 1.5)-GLSZM-ZonVar
45 Sqrt-GLRLM-RunLenNonUniform 46 Lobe#5 VPO HU4
47 LoG(σ = 2.5)-GLCM-Imc2 48 LoG(σ = 1.5)-GLSZM-LALG
49 HHH-GLCM-SumAverage 50 Left Lung VPO HU3
51 HHH-GLCM-JointAverage 52 Left Lung RPO HU3
Red text indicates non-imaging features.
Green text indicates lobe-wise quantification features, HU1-HU4 are the four HU intervals.
Blue text indicates whole lung radiomics features encoded as Filter-FeatureType-
Parameter.
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